436 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical ... Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... mcclaffertyMD #SGLT2
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... metformin in T2D and CKD ... receptor agonist SGLT2i ... , #KDIGO2020 #CKD ... Management in CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
-4 inhibitors SGLT2 ... Improved outcomes in CKD
COVID-19 Dermatologic Manifestations 

#covid19 #covidtoes #dermatology #dermatologic #COVID19 #sarscov2 #clinical #skin
COVID-19 Dermatologic ... covid19 #covidtoes #dermatology ... #dermatologic # ... COVID19 #sarscov2 #clinical
Complications of CKD
 - Patients with stages 1-3 ([GFR] >30 mL/min) of CKD are generally asymptomatic;
Complications of CKD ... >30 mL/min) of CKD ... derangements are not clinically ... disturbances manifest clinically ... in CKD stages 4
Expected DAT Results in Autoimmune Hemolysis
DAT Negative Hemolysis
 • DAT Poly ( - ), IgG (
), IgG ( - ), C3d ... ), IgG ( + ), C3d ... ), IgG ( - ), C3d ... , IgG ( +/- ), C3d ... Autoimmune #Hemolysis #hematology
#VisualAbstract for #Lancet trial #CANVASR #SGLT2i #Canagliflozin

"Canagliflozin and renal outcomes in type 2 diabetes: results from
trial #CANVASR #SGLT2i ... Program randomised clinical
Chronic Kidney Disease (CKD):

Individualize BP-lowering therapy and treatment targets in people with frailty, high risk of
Kidney Disease (CKD ... progression of CKD ... include RASiand SGLT2i ... heart failure, SGLT2i ... both RASI and SGLT2i
Dermatology Skin Lesion Atlas

#Skin #Lesions #Atlas #Map #Nomenclature #Dermatology #Naming #Terminology #Clinical

** GrepMed Recommended Text: Fitzpatrick's
Dermatology Skin ... #Nomenclature #Dermatology ... #Terminology #Clinical
Algorithmic Approach to Anemia - Differential Diagnosis Framework by MCV

Microcytic (MCV < 80) "TAILS":
 • Thalassemia
Aplastic anemia, CKD ... Differential #Diagnosis #hematology